Trial intelligence / Profile preview

Intravenous amino acids during ileal pouch-anal anastomosis for ulcerative colitis

2014-000784-41Phase 3Terminated

Sponsor
Department of Medicine and Endocrinology
Start
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in autoimmune colitis comparing Vaminolac with Placebo (2 arms). Primary endpoints: Palmitate balance by tracer kinetics, Tyrosine balance by tracer kinetics and 1 more. Started Jan 2015; status: terminated.

02

Drugs

Vaminolac
03

Conditions

autoimmune colitis

Beyond the preview

Go deeper on 2014-000784-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000784-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call